From The Helm: Immutep's (ASX:IMM) Executive Director & CEO Marc Voigt The Bellcast podcast

Artwork

Trading Business Bell Direct Online Share Trading Ausbiz Asx200 Investing Economics

内容由Bell Direct提供。所有播客内容（包括剧集、图形和播客描述）均由 Bell Direct 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

The Bellcast « »
From the helm: Immutep's (ASX:IMM) Executive Director & CEO Marc Voigt

3y ago 8:11

分享

MP3•单集首页

内容由Bell Direct提供。所有播客内容（包括剧集、图形和播客描述）均由 Bell Direct 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

In this instalment of our From the helm series, Bell Direct’s Jessica Amir speaks to Immutep's (ASX:IMM) Executive Director and CEO, Marc Voigt.
Immutep has gained a lot of attention, as its trials in collaboration with big-names, Pfizer and Merck, has seen a remission in patients' tumours. Between capital raisings and partnerships, Immutep continues to deliver impressive results...
In this video Marc discusses:
- (0:40) IMM's progress: the year that was, and the year ahead
- (1:30) Promising results from an IMM study in collaboration with Pfizer and Merck
- (2:29) Its unique discovery in immunotherapy - which spells new opportunities
- (4:02) Key catalysts that could drive share price growth
- (6:00) Fund managers who bought into IMM recently - and how funds raised will be spent
This interview was filmed on 18 August 2021.

… continue reading

57集单集

#Trading #Business #Bell Direct #Online Share Trading #Ausbiz #Asx200 #Investing #Economics

Artwork

From the helm: Immutep's (ASX:IMM) Executive Director & CEO Marc Voigt

published 3y ago

分享

MP3•单集首页

内容由Bell Direct提供。所有播客内容（包括剧集、图形和播客描述）均由 Bell Direct 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

In this instalment of our From the helm series, Bell Direct’s Jessica Amir speaks to Immutep's (ASX:IMM) Executive Director and CEO, Marc Voigt.
Immutep has gained a lot of attention, as its trials in collaboration with big-names, Pfizer and Merck, has seen a remission in patients' tumours. Between capital raisings and partnerships, Immutep continues to deliver impressive results...
In this video Marc discusses:
- (0:40) IMM's progress: the year that was, and the year ahead
- (1:30) Promising results from an IMM study in collaboration with Pfizer and Merck
- (2:29) Its unique discovery in immunotherapy - which spells new opportunities
- (4:02) Key catalysts that could drive share price growth
- (6:00) Fund managers who bought into IMM recently - and how funds raised will be spent
This interview was filmed on 18 August 2021.

… continue reading

57集单集

#Trading #Business #Bell Direct #Online Share Trading #Ausbiz #Asx200 #Investing #Economics

Tất cả các tập

×

欢迎使用Player FM

Player FM正在网上搜索高质量的播客，以便您现在享受。它是最好的播客应用程序，适用于安卓、iPhone和网络。注册以跨设备同步订阅。

收听超过500个主题